Prior to co-founding Vitruvia, Christian Seale brings a diverse and successful track record as a healthcare investor and entrepreneur. His investment portfolio includes over 30 innovative healthtech companies seven of which have been acquired.
Christian is a Founding Member of NextGen Venture Partners and previously worked with consumer-only VC firm Maveron, Goldman Sachs and Teach for America. Before his healthcare work, Christian was a founding member of Equitable Origin, the world’s first certification for responsible energy production which was featured in the award-winning PBS documentary Oil & Water. Christian is a World Economic Forum Global Shaper and a Fulbright Scholar. He is an active contributor to Univision and TechCrunch.
Christian earned his MBA from Harvard Business School and graduated Phi Beta Kappa and magna cum laude from Brown University.
Dr. Scheffer C. G. Tseng co-founded TissueTech and Bio-Tissue and is currently Chief Technology Officer for TissueTech. Dr. Tseng is a world-renowned surgeon in ocular surface reconstruction and a widely published physician scientist with more than 380 peer-reviewed clinical and scientific papers. He pioneered limbal stem cell transplantation and developed and commercialized the CRYOTEK process to preserve the natural therapeutic properties of amniotic membrane. His research focus for the past 35 years has been to identify the active biological components of human placental tissues, to develop alternative products to deliver their therapeutic properties, and to expand their clinical applications. Dr. Tseng holds a medical degree from National Taiwan University and a Doctorate in Experimental Pathology from the University of California. He completed his residency in ophthalmology at the Wilmer Eye Institute at Johns Hopkins, and his fellowship in cornea and external diseases at Massachusetts Eye and Ear Infirmary. Prior to co-founding TissueTech, Dr. Tseng was a Chair Professor at Bascom Palmer Eye Institute, University of Miami Miller School of Medicine.